Top Story
PetScreen co-sponsors two MAF canine cancer studies
Salina Christmas, Web Editor
06 November 2007
 |
| Graeme Radcliffe (pictured, right) with his dogs Libby, Hugo and Saskia, and Dr Kevin Slater (pictured, left) |
MAF Canine Cancer Campaign is seeking to prevent canine cancer, while immediately seeking treatment advancements to help dogs suffering from cancer today.
“We are delighted to be able to support the Morris Animal Foundation in their efforts to combat cancer in dogs,” said Graeme Radcliff, founder of PetScreen. “Having suffered the loss of three of our family’s precious dogs to cancer, PetScreen represents the culmination of a personal battle for me and my wife, Eileen, to help fight this disease, which is all too prevalent in the canine world.”
The donation was made in the name of Mr Radcliffe’s family’s three current dogs: Libbi, a chocolate Labrador, Saskia, a German shepherd, and Hugo, an Irish water spaniel.
Dr Kevin Slater, chief executive of PetScreen, commented: “Having developed a screening test for canine lymphoma, we are now working hard to refine its application to the benefit of dogs, owners and their veterinarians.”
 |
| PetScreen's founders Dr Kevin Slater (pictured, left) and Graeme Radcliffe. "We have learned a great deal about applying new technology to improve pet health. Every day we are striving to learn more," says Dr Slater |
“Morris Animal Foundation greatly appreciates PetScreen’s donation to help us address the leading cause of death in dogs over the age of two,” said Dr Patricia Olson, president and CEO of MAF. “We hope other companies in the US, the UK and around the world will step up and help us fund this valuable research.”
She added that the very same cancer research breakthroughs benefiting dogs are having direct benefit to humans suffering from cancer. “Here again, the dog is proving itself to be man’s best friend,” said Dr Olson.
About Morris Animal Foundation: Morris Animal Foundation, established in 1948, is dedicated to funding research that protects, treats and cures companion animals and wildlife. MAF has been at the forefront of funding breakthrough research studies benefiting animals in some 100 countries. MAF has its headquarters in Denver, Colorado, US. The foundation has funded nearly 1,400 humane animal health studies with funds totaling more than US$51 million. One hundred percent of annual, unrestricted contributions support animal health programs. For details, call +1 (800) 243-2345, or visit www.MorrisAnimalFoundation.org and www.CureCanineCancer.org
About PetScreen: PetScreen was founded by people who have lost their pets to cancer and by scientists who have years of experience working on new methods used in the study and treatment of cancer. It uses the latest scientific developments to make animal cancer therapy kinder and more effective. Its headquarters and laboratories are based in Nottingham, England. PetScreen is developing a network of collaborators in the UK and US who provide services and support to the veterinary cancer patient. If cancer is detected, PetScreen is able to provide a directed chemotherapy assay (DCA) which highlights resistance from the start and identifies the treatment most likely to be effective for an individual patient. For details, visit www.pet-screen.com
Email a friend
Digital RSS Feed
